Skip to main content

GOSSAMER BIO SHAREHOLDER ALERT: Class Action Lawsuit Filed

BOSTON, MA / ACCESSWIRE / April 7, 2020 / Thornton Law Firm LLP announces that a lawsuit has been filed against Gossamer Bio, Inc. on behalf of GOSS shareholders (NYSE:GOSS). Investors who purchased stock in connection to the IPO or between February 8, 2019 and December 13, 2019, that are interested to serve as a lead plaintiff are encouraged to visit https://www.tenlaw.com/cases/GOSS. Shareholders may also contact Thornton Law Firm at shareholder@tenlaw.com, or call 617-531-3917. There is no minimum number of shares required to be a class member.

FOR MORE INFORMATION, VISIT: https://www.tenlaw.com/cases/GOSS

Interested GOSS shareholders have until June 2, 2020 to apply to be a lead plaintiff. The lawsuit alleges violations of the federal securities laws, and the class has not yet been certified. Until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. There is no minimum number of shares required to be a class member.

Gossamer is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology.

The Complaint alleges that the materials supporting the IPO, and certain of the Company's post-IPO public filings, defendants made materially false and misleading statements relevant to Gossamer's GB001 drug and its related clinical trials and studies. It is alleged that on December 16, 2019, Novartis announced that it was terminating the development of its DP2 antagonist for asthma after it failed a pair of phase 3 clinical trials. The lawsuit alleges that as a result, Gossamer's common stock dropped by approximately 37% in one day and investors suffered damages.

If you have purchased GOSS stock (NYSE: GOSS) please contact the Thornton Law Firm's shareholder rights team at http://www.tenlaw.com/cases/GOSS, by email at shareholder@tenlaw.com, or calling 617-531-3917 to discuss the lead plaintiff process.

FOR MORE INFORMATION: https://www.tenlaw.com/cases/GOSS

Thornton Law Firm's securities attorneys are highly experienced in representing individual shareholders and institutional investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of shareholders. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:

Thornton Law Firm LLP
State Street Financial Center
1 Lincoln Street
Boston, MA 02111
www.tenlaw.com/cases/GOSS

SOURCE: Thornton Law Firm LLP



View source version on accesswire.com:
https://www.accesswire.com/584229/GOSSAMER-BIO-SHAREHOLDER-ALERT-Class-Action-Lawsuit-Filed

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.